Evidence map›Paper›PMID 23589620›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion.

Samuel Amoah, Beth C Holbrook, Rama D Yammani, Martha A Alexander-Miller

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samuel AmoahDepartment of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Beth C Holbrook
Rama D Yammani
Martha A Alexander-Miller

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Cellular Immune Response to Respiratory InfectionR01HL071985 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALEXANDER-MILLER, MARTHA ANN · 2004 to 2010
$2.4M
Control of cytotoxic T cell differentiation and activityR01AI043591 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALEXANDER-MILLER, MARTHA ANN · 1999 to 2009
$2.2M
NCI NIH HHS P30 CA012197NHLBI NIH HHS R01 HL071985NIAID NIH HHS R01 AI043591
6 · The paper itself

Abstract

Generating and maintaining a robust CD8(+) T cell response in the face of high viral burden is vital for host survival. Further, balancing the differentiation of effectors along the memory precursor effector cell pathway versus the short-lived effector cell (SLEC) pathway may be critical in controlling the outcome of virus infection with regard to clearance and establishing protection. Although recent studies have identified several factors that have the capacity to regulate effector CD8(+) T cell differentiation-for example, inflammatory cytokines-we are far from a complete understanding of how cells choose the memory precursor effector cell versus SLEC fate following infection. In this study, we have modulated the infectious dose of the poxvirus vaccinia virus as an approach to modulate the environment present during activation and expansion of virus-specific effector cells. Surprisingly, in the face of a high virus burden, the number of SLECs was decreased. This decrease was the result of increased natural regulatory T cells (Tregs) generated by high viral burden, as depletion of these cells restored SLECs. Our data suggest Treg modulation of differentiation occurs via competition for IL-2 during the late expansion period, as opposed to the time of T cell priming. These findings support a novel model wherein modulation of the Treg response as a result of high viral burden regulates late-stage SLEC number.

Indexed as

AnimalsB-Lymphocyte SubsetsCaspase 3CD8-Positive T-LymphocytesCell DifferentiationCell ProliferationCTLA-4 AntigenFemaleGlucocorticoid-Induced TNFR-Related ProteinInterleukin-12Interleukin-2Interleukin-2 Receptor alpha SubunitLectins, C-TypeMiceMice, Inbred C57BLReceptors, ImmunologicCaspase 3CTLA-4 AntigenCtla4 protein, mouseGlucocorticoid-Induced TNFR-Related ProteinInterleukin-12Interleukin-2Interleukin-2 Receptor alpha SubunitKlrg1 protein, mouseLectins, C-TypeReceptors, ImmunologicSTAT5 Transcription FactorTnfrsf18 protein, mouse

Identifiers

PMID23589620
PMCPMC3711656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.